Bayer Schering Pharma AG
Overview
Bayer Schering Pharma AG was a pharmaceutical company known for its innovation in healthcare, focusing on areas such as oncology, women's healthcare, and cardiology. It was a subsidiary of Bayer AG, a global enterprise with core competencies in the Life Science fields of health care and nutrition.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Bayer Schering Pharma AG is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Bayer Schering Pharma AG holds 0 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- FLUDARA FILM-COATED TABLETSInactive2007-03-07
- ASOPRISNILInactive2004-07-15
- FLUDARABINE PHOSPHATEInactive2000-06-15
- ILOPROST B-CYCLODEXRIN CLATHRATEInactive1995-10-12
- MEGESTROL ACETATEInactive1984-03-15
- HYDROCORTISONEInactive1982-11-30
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Bayer Schering Pharma AG in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Bayer Schering Pharma AG? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.